• 1
    Caulkins J. P., Reuter P., Coulson C. Basing drug scheduling decisions on scientific ranking of harmfulness: false promise from false premises. Addiction 2011; Epub ahead of print. doi:10.1111/j.1360-0443.2011.03461.x.
  • 2
    Nutt D., King L. A., Saulsbury W., Blakemore C. Development of a rational scale to assess the harm of drugs of potential misuse. Lancet 2007; 369: 104753.
  • 3
    Nutt D. J., King L. A., Phillips L. D. Drug harms in the UK: a multicriteria decision analysis. Lancet 2010; 376: 155865.
  • 4
    Best D., Gross D., Vingoe L., Wilton J., Strang J. Dangerousness of Drugs: A Guide to the Risks and Harms Associated with Substance Use. London: UK Department of Health; 2003.
  • 5
    Roques B. La dangerosité des drogues: rapport au Secrétariat d'État à la Santé[The dangerousness of drugs: report to the State Secretariat for Health]. Paris: La Documentation française—Odile Jacob; 1999.
  • 6
    Room R., Lubman D. I. Politics and science in classifying the dangers of drugs. Evid Based Ment Health 2010; 13: 979.
  • 7
    Kalant H. Drug classification: science, politics, both or neither? Addiction 2010; 105: 11469.
  • 8
    Jaffe J. H., Jaffe F. K. Historical perspectives on the use of subjective effects measures in assessing the abuse potential of drugs. In: Fischman M. W., Mello N. K., editors. Testing for Abuse Liability of Drugs in Humans. NIDA Research Monograph no. 92. Rockville, MD: National Institute on Drug Abuse; 1989, p. 4369.
  • 9
    Room R. Alcohol and drug disorders in the international classification of diseases: a shifting kaleidoscope. Drug Alcohol Rev 1998; 17: 30517.
  • 10
    Babor T., Caulkins J., Edwards G., Fischer B., Foxcroft D., Humphreys K. et al. Drug Policy and the Public Good. Oxford: Oxford University Press; 2010, p. 2178.
  • 11
    Lenton S., Heale P. Arrest, court and social impacts of conviction for a minor cannabis offence under strict prohibition. Contemp Drug Probl 2000; 27: 80533.